Nitin Goyal

Nitin Goyal

Auto-generated profile, based on publicly available information

Nitin Goyal

Department of Neurology, Semmes Murphey Clinic, University of Tennessee Health Sciences Center, Memphis (N.G., C.T.S.).

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
ASAmrou Sarraj
Amrou Sarraj
NSNavdeep Sangha
Navdeep Sangha
MHMuhammad Shazam Hussain
Muhammad Shazam Hussain
DWDolora Wisco
Dolora Wisco
NVNirav Vora
Nirav Vora
RGRishi Gupta
Rishi Gupta
Five recently published randomized clinical trials (RCTs)1-5 demonstrated the superiority of endovascular therapy (EVT) compared with best medical management, including intravenous tissue plasminogen activator (IV tPA) therapy for acute ischemic strokes with large vessel occlusion (LVO) in the anterior circulation. However, the RCTs’ inclusion criteria focused on proximal occlusions involving the distal internal carotid artery and proximal (first segment [M1]) middle cerebral artery (MCA). Patients with more distal occlusions in the second-order branches (M2) of the MCA, however, were underrepresented in the trials. ESCAPE (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT [Computed Tomography] to Recanalization Times),2 SWIFT PRIME (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke),4 and REVASCAT (Randomized Trial of Revascularization With Solitaire FR Device vs Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within 8 Hours of Symptom Onset)5 restricted enrollment to patients with more proximal occlusions, although a few patients were misclassified as having M1 segment occlusion by the enrolling center and were subsequently adjudicated by the core laboratory as having M2 segment occlusion. MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands)1 and EXTEND-IA (Extending the Time for Thrombolysis in Emergency Neurological Deficits–Intra-arterial)3 enrolled only a few patients with distal occlusions. Of 1287 patients enrolled in the 5 trials, only a total of 94 patients were randomized; 51 of these patients received EVT. Evidence from RCTs regarding the benefit of EVT is therefore lacking for M2 segment occlusions, as reflected in the recent American Heart Association guidelines.6

8 August 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
NGNitin Goyal
Nitin Goyal
GTGeorgios Tsivgoulis
Georgios Tsivgoulis
APAbhi Pandhi
Abhi Pandhi
JCJason J. Chang
Jason J. Chang
KDKira Dillard
Kira Dillard
AAAndrei V. Alexandrov
Andrei V. Alexandrov
Objective: There are limited data evaluating the effect of post mechanical thrombectomy (MT) blood pressure (BP) levels on early outcomes of patients with large vessel occlusions (LVO). We sought to investigate the association of BP course following MT with early outcomes in LVO. Methods: Consecutive patients with LVO treated with MT during a 3-year period were evaluated. Hourly systolic BP (SBP) and diastolic BP (DBP) values were recorded for 24 hours following MT and maximum SBP and DBP levels were identified. LVO patients with complete reperfusion following MT were stratified in 3 groups based on post-MT achieved BP goals: <140/90 mm Hg (intensive), <160/90 mm Hg (moderate), and <220/110 mm Hg or <180/105 mm Hg when pretreated with IV thrombolysis (permissive hypertension). Three-month functional independence was defined as modified Rankin Scale score of 0–2. Results: A total of 217 acute ischemic stroke patients with LVO were prospectively evaluated. A 10 mm Hg increment in maximum SBP documented during the first 24 hours post MT was independently (p = 0.001) associated with a lower likelihood of 3-month functional independence (odds ratio [OR] 0.70; 95% confidence interval [CI] 0.56–0.87) and a higher odds of 3-month mortality (OR 1.49; 95% CI 1.18–1.88) after adjusting for potential confounders. In addition, achieving a BP goal of <160/90 mm Hg during the first 24 hours following MT was independently associated with a lower likelihood of 3-month mortality (OR 0.08; 95% CI 0.01–0.54; p = 0.010) in comparison to permissive hypertension. Conclusions: High maximum SBP levels following MT are independently associated with increased likelihood of 3-month mortality and functional dependence in LVO patients. Moderate BP control is also related to lower odds of 3-month mortality in comparison to permissive hypertension.

1 June 2016 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
Georgios TsivgoulisGeorgios Tsivgoulis
Georgios Tsivgoulis
Ramin ZandRamin Zand
Ramin Zand
AKAristeidis H. Katsanos
Aristeidis H. Katsanos
GTGuillaume Turc
Guillaume Turc
CNChristian H. Nolte
Christian H. Nolte
AAAndrei V. Alexandrov
Andrei V. Alexandrov
Cerebral microbleeds (CMBs) as visualized on gradient echo T2* or susceptibility-weighted magnetic resonance imaging (MRI) are considered markers of bleeding-prone cerebral vessel microangiopathies and constitute both significant and independent predictors of future cerebral bleeding.1-3 Several clinical studies have associated CMB presence with hemorrhagic stroke and hemorrhagic complications following antithrombotic medications.4

1 May 2015 in Stroke
Verified
Journal Article
Closed access
Georgios TsivgoulisGeorgios Tsivgoulis
Georgios Tsivgoulis
Ramin ZandRamin Zand
Ramin Zand
AKAristeidis H. Katsanos
Aristeidis H. Katsanos
NGNitin Goyal
Nitin Goyal
KUKen Uchino
Ken Uchino
AAAndrei V. Alexandrov
Andrei V. Alexandrov
Background and Purpose—: Shortening door-to-needle time may lead to inadvertent intravenous thrombolysis (IVT) administration in stroke mimics (SMs). We sought to determine the safety of IVT in SMs using prospective, single-center data and by conducting a comprehensive meta-analysis of reported case-series. Methods—: We prospectively analyzed consecutive IVT-treated patients during a 5-year period at a tertiary care stroke center. A systematic review and meta-analysis of case-series reporting safety of IVT in SMs and confirmed acute ischemic stroke were conducted. Symptomatic intracerebral hemorrhage was defined as imaging evidence of ICH with an National Institutes of Health Stroke scale increase of ≥4 points. Favorable functional outcome at hospital discharge was defined as a modified Rankin Scale score of 0 to 1. Results—: Of 516 consecutive IVT patients at our tertiary care center (50% men; mean age, 60±14 years; median National Institutes of Health Stroke scale, 11; range, 3–22), SMs comprised 75 cases. Symptomatic intracerebral hemorrhage occurred in 1 patient, whereas we documented no cases of orolingual edema or major extracranial hemorrhagic complications. In meta-analysis of 9 studies (8942 IVT-treated patients), the pooled rates of symptomatic intracerebral hemorrhage and orolingual edema among 392 patients with SM treated with IVT were 0.5% (95% confidence interval, 0%–2%) and 0.3% (95% confidence interval, 0%–2%), respectively. Patients with SM were found to have a significantly lower risk for symptomatic intracerebral hemorrhage compared with patients with acute ischemic stroke (risk ratio=0.33; 95% confidence interval, 0.14–0.77; P =0.010), with no evidence of heterogeneity or publication bias. Favorable functional outcome was almost 3-fold higher in patients with SM in comparison with patients with acute ischemic stroke (risk ratio=2.78; 95% confidence interval, 2.07–3.73; P <0.00001). Conclusions—: Our prospective, single-center experience coupled with the findings of the comprehensive meta-analysis underscores the safety of IVT in SM.

1 January 2020 in JAMA Neurology
Verified
Journal Article
Closed access
PDF file
NGNitin Goyal
Nitin Goyal
GTGeorgios Tsivgoulis
Georgios Tsivgoulis
KMKonark Malhotra
Konark Malhotra
MIMuhammad F. Ishfaq
Muhammad F. Ishfaq
APAbhi Pandhi
Abhi Pandhi
AAAdam S. Arthur
Adam S. Arthur
Importance The benefit of mechanical thrombectomy (MT) in patients with stroke presenting with mild deficits (National Institutes of Health Stroke Scale [NIHSS] score <6) owing to emergency large-vessel occlusion (ELVO) remains uncertain. Objective To assess the outcomes of patients with mild-deficits ELVO (mELVO) treated with MT vs best medical management (bMM). Data Sources We retrospectively pooled patients with mELVO during a 5-year period from 16 centers. A meta-analysis of studies reporting efficacy and safety outcomes with MT or bMM among patients with mELVO was also conducted. Data were analyzed between 2013 and 2017. Study Selection We identified studies that enrolled patients with stroke (within 24 hours of symptom onset) with mELVO treated with MT or bMM. Main Outcomes and Measures Efficacy outcomes included 3-month favorable functional outcome and 3-month functional independence that were defined as modified Rankin Scale scores of 0 to 1 and 0 to 2, respectively. Safety outcomes included 3-month mortality and symptomatic and asymptomatic intracranial hemorrhage (ICH). Results We evaluated a total of 251 patients with mELVO who were treated with MT (n = 138; 65 women; mean age, 65.2 years; median NIHSS score, 4; interquartile range [IQR], 3-5) or bMM (n = 113; 51 women; mean age, 64.8; median NIHSS score, 3; interquartile range [IQR], 2-4). The rate of asymptomatic ICH was lower in bMM (4.6% vs 17.5%;P = .002), while the rate of 3-month FI (after imputation of missing follow-up evaluations) was lower in MT (77.4% vs 88.5%;P = .02). The 2 groups did not differ in any other efficacy or safety outcomes. In multivariable analyses, MT was associated with higher odds of asymptomatic ICH (odds ratio [OR], 11.07; 95% CI, 1.31-93.53;P = .03). In the meta-analysis of 4 studies (843 patients), MT was associated with higher odds of symptomatic ICH in unadjusted analyses (OR, 5.52; 95% CI, 1.91-15.49;P = .002;I2 = 0%). This association did not retain its significance in adjusted analyses including 2 studies (OR, 2.06; 95% CI, 0.49-8.63;P = .32;I2 = 0%). The meta-analysis did not document any other independent associations between treatment groups and safety or efficacy outcomes. Conclusions and Relevance Our multicenter study coupled with the meta-analysis suggests similar outcomes of MT and bMM in patients with stroke with mELVO, but no conclusions about treatment effect can be made. The clinical equipoise can further be resolved by a randomized clinical trial.

1 March 2016 in Stroke
Verified
Journal Article
Open access
PDF file
MMMaxim Mokin
Maxim Mokin
ASAshish Sonig
Ashish Sonig
SSSananthan Sivakanthan
Sananthan Sivakanthan
ZRZeguang Ren
Zeguang Ren
LELucas Elijovich
Lucas Elijovich
ASAdnan H. Siddiqui
Adnan H. Siddiqui
Background and Purpose—Patients with posterior circulation strokes have been excluded from recent randomized endovascular stroke trials. We reviewed the recent multicenter experience with endovascular treatment of posterior circulation strokes to identify the clinical, radiographic, and procedural predictors of successful recanalization and good neurological outcomes. Methods—We performed a multicenter retrospective analysis of consecutive patients with posterior circulation strokes, who underwent thrombectomy with stent retrievers or primary aspiration thrombectomy (including A Direct Aspiration First Pass Technique [ADAPT] approach). We correlated clinical and radiographic outcomes with demographic, clinical, and technical characteristics. Results—A total of 100 patients were included in the final analysis (mean age, 63.5±14.2 years; mean admission National Institutes of Health Stroke Scale score, 19.2±8.2). Favorable clinical outcome at 3 months (modified Rankin Scale score ≤2) was achieved in 35% of patients. Successful recanalization and shorter time from stroke onset to the start of the procedure were significant predictors of favorable clinical outcome at 90 days. Stent retriever and aspiration thrombectomy as primary treatment approaches showed comparable procedural and clinical outcomes. None of the baseline advanced imaging modalities (magnetic resonance imaging, computed tomographic perfusion, or computed tomography angiography assessment of collaterals) showed superiority in selecting patients for thrombectomy. Conclusions—Time to the start of the procedure is an important predictor of clinical success after thrombectomy in patients with posterior circulation strokes. Both stent retriever and aspiration thrombectomy as primary treatment approaches are effective in achieving successful recanalization.